Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Farmers Insurance

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 7,914,542

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,914,542
Title:Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
Abstract: Devices, systems and methods for compressing, cutting, incising, reconfiguring, remodeling, attaching, repositioning, supporting, dislocating or altering the composition of tissues or anatomical structures to alter their positional or force relationship to other tissues or anatomical structures. In some applications, the invention may be used to used to improve patency or fluid flow through a body lumen or cavity (e.g., to limit constriction of the urethra by an enlarged prostate gland).
Inventor(s): Lamson; Theodore Charles (Pleasanton, CA), Makower; Joshua (Los Altos, CA), Catanese, III; Joseph (San Leandro, CA), Welch; Jacqueline Nerney (Pacifica, CA), Walke; Amrish Jayprakash (Santa Clara, CA), Vidal; Claude (Santa Barbara, CA), Redmond; Russell J. (Goleta, CA), Collinson; Michael (Goleta, CA)
Assignee: Neotract, Inc. (Pleastanton, CA)
Application Number:11/838,036
Patent Claims:see list of patent claims

Details for Patent 7,914,542

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Try a Free Trial Neotract, Inc. (Pleastanton, CA) 2025-05-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Federal Trade Commission
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.